Cargando…
Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
Hematological profiles are measurable indices of blood that can be used to identify and monitor some pathological and physiological abnormalities. Oral contraceptives are one of the factors which may exert an influence on hematological laboratory test results and have a critical importance. Therefor...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528910/ https://www.ncbi.nlm.nih.gov/pubmed/36199529 http://dx.doi.org/10.2147/JBM.S379841 |
_version_ | 1784801390775762944 |
---|---|
author | Tekle, Esayas Gelaw, Yemataw Asrie, Fikir |
author_facet | Tekle, Esayas Gelaw, Yemataw Asrie, Fikir |
author_sort | Tekle, Esayas |
collection | PubMed |
description | Hematological profiles are measurable indices of blood that can be used to identify and monitor some pathological and physiological abnormalities. Oral contraceptives are one of the factors which may exert an influence on hematological laboratory test results and have a critical importance. Therefore, the main goal of this review was to evaluate the hematologic profile alterations brought on by the use of oral contraceptives. Accordingly, even though there were studies that showed no significant difference, most of the oral contraceptive users had higher hemoglobin, platelet, and erythrocyte counts than non-users. Other erythrocyte metrics, such as mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration and red cell dispersion width, did not significantly change. Moreover, leukocyte count and leukocyte differential count had no significant change among the oral contraceptive users in comparison to non-users. Oral contraceptive users typically have shorter prothrombin times, activated partial thromboplastin times, thrombin times, and greater levels of fibrinogen and D-dimer compared to non-users. However, this review is a narrative review and did not show the pooled effect of oral contraceptives on these hematological parameters. Therefore, it is recommended to do systematic and meta-analysis to determine the pooled effect of oral contraceptives. |
format | Online Article Text |
id | pubmed-9528910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-95289102022-10-04 Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review Tekle, Esayas Gelaw, Yemataw Asrie, Fikir J Blood Med Review Hematological profiles are measurable indices of blood that can be used to identify and monitor some pathological and physiological abnormalities. Oral contraceptives are one of the factors which may exert an influence on hematological laboratory test results and have a critical importance. Therefore, the main goal of this review was to evaluate the hematologic profile alterations brought on by the use of oral contraceptives. Accordingly, even though there were studies that showed no significant difference, most of the oral contraceptive users had higher hemoglobin, platelet, and erythrocyte counts than non-users. Other erythrocyte metrics, such as mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration and red cell dispersion width, did not significantly change. Moreover, leukocyte count and leukocyte differential count had no significant change among the oral contraceptive users in comparison to non-users. Oral contraceptive users typically have shorter prothrombin times, activated partial thromboplastin times, thrombin times, and greater levels of fibrinogen and D-dimer compared to non-users. However, this review is a narrative review and did not show the pooled effect of oral contraceptives on these hematological parameters. Therefore, it is recommended to do systematic and meta-analysis to determine the pooled effect of oral contraceptives. Dove 2022-09-29 /pmc/articles/PMC9528910/ /pubmed/36199529 http://dx.doi.org/10.2147/JBM.S379841 Text en © 2022 Tekle et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Tekle, Esayas Gelaw, Yemataw Asrie, Fikir Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review |
title | Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review |
title_full | Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review |
title_fullStr | Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review |
title_full_unstemmed | Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review |
title_short | Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review |
title_sort | hematological profile changes among oral contraceptive users: a narrative review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528910/ https://www.ncbi.nlm.nih.gov/pubmed/36199529 http://dx.doi.org/10.2147/JBM.S379841 |
work_keys_str_mv | AT tekleesayas hematologicalprofilechangesamongoralcontraceptiveusersanarrativereview AT gelawyemataw hematologicalprofilechangesamongoralcontraceptiveusersanarrativereview AT asriefikir hematologicalprofilechangesamongoralcontraceptiveusersanarrativereview |